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THE PROBLEM 
A good understanding of predictors of hypertension should allow the se- 
lection of populations with a sufficiently high incidence of later hypertension 
to warrant preventive use of antihypertensive drugs. Much more work on 
predictors of hypertension is needed, however, before it will be possible to 
select such a group. This is illustrated by the best-known and strongest pre- 
dictor of future hypertension-so-called borderline hypertension. We use the 
term “borderline hypertension” to apply to persons ( 1 ) whose blood pressure 
oscillates between normal (139/89 or less) and elevated ( > 139/89) values 
and (2) to persons whose average casual blood pressure is in the range of 
140-160/90-100. In borderline hypertension, the risk of future hypertension 
is higher than in the general population; however, the risk is not overwhelming 
and the majority of patients will not develop hypertension; thus, patients with 
borderline hypertension cannot be treated as a uniform population with excess 
morbidity, and it is important to identify the subgroup of future hypertensive 
patients. The papers upon which this statement are based l-l0 have been dis- 
cussed in a previous review.” The validity of the statement can be illustrated 
in the light of results of efficacy of the antihypertensive treatment in mild 
hypertension utilizing the data from the Veterans Administration Cooperative 
Study.12 
Consider the following projection based on the assumptions that : ( 1 ) the 
treatment is likely to be less effective in borderline hypertension than in mild 
hypertension described in the VA Study; and (2) in 5 years 10% of patients 
with borderline hypertension would progress to develop hypertension of the 
degree investigated in the VA Study (sustained diastolic 90-115). The first 
assumption need not be defended; the lower the initial blood pressure, the 
less is the effectiveness of the treatment.12. l3 The 10% figure for a 5-year 
incidence of hypertension is based on available literature for middle-aged 
subjects with previous borderline hypertension (Table 3 in reference 1 1). 
Using the VA article, page 167, and Figure 2 (page 168), and a 5-year 
follow-up, the following values were obtained: 
1. If hypertensives with diastolic blood pressure between 90-114 mm Hg 
are untreated, 55% will have a morbid event in five years. 
2. The standard deviation for this untreated rate is 4.0%. 
Thus, using an approximate 95% confidence interval (+ 2 S.D.) to find a 
range of untreated values, we get: 
lower limit for 5-year untreated rate: 55% - 8% = 47% 
upper limit for 5-year untreated rate: 55% + 8% = 63%. 
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Now, using 47%, 55% and 63% as three untreated 5-year percentages of 
patients having a morbid event, we can consider several choices for “effective 
reduction” in that percentage due to treatment. Suppose we take for these: 
reduced by 45 (VA result), %, and Y,, a 67%, 50% and 25% reduction, 
respectively. 
With these values we can illustrate various percentages of persons at risk 
(to develop diastolic blood pressure 90-114 mm Hg during the proposed 
period of treatment) who will be “saved” from a morbid event in the next 
five years, if the entire population with borderline hypertension is treated with 
antihypertensive therapy. 
TABLE 1 
PERCENTAGE OF TOTAL POPULATION OF BORDERLINE HYPERTENSIVES WHO WOULD 
BE SAVED FROM A MORBID EVENT BY VARIOUS POSTULATED 
TREATMENT EFFICACIES * 
Efficacy of Treatment 
Untreated Morbidity 
For Hypertensives U (67%) Ih (50%) ?4 (25%) 
3.13 2.35 1.17 















* The percentages in italics assume 80% instead of 100% of the subjects adhere to 
the treatment. 
The assumptions in TABLE 1 can be changed. To find percentage “saved” for popu- 
lations with different percentages at risk, multiply the value in table by the appro- 
priate multiple of 10%: e.g., if 30% of population have diastolic blood pressure 
90-114 mm Hg and untreated percentage is 5 5 % ,  U reduction, 3.67~3=11.01% 
are “saved”. 
To find percentage “saved” for population with adherence other than loo%, 
multiply the value in table by percent adhering; e.g., if untreated percentage is 55% 
and U reduction and 80% adhere, 3.67~0.80=2.94%. 
If the proportion at risk (to develop diastolic 90-1 14 mm Hg) is l o % ,  the 
values for the percentage “saved” can be calculated (TABLE 1 ) . 
There are obvious limitations to the calculations presented in TABLE 1. 
Treatment in younger persons may be more beneficial than in middle-aged 
subjects investigated in the VA Study. We assumed that the treatment at lower 
blood pressure levels will be less effective than in the VA Study, but some 
unaccounted usefulness at these lower levels may exist. However, on the 
whole, the projection in TABLE 1 is weighted in favor of the treatment. An 
unusually high rate of patient compliance has been anticipated. In practice one 
could not expect the compliance to approach levels demonstrated in the VA 
Study. In that study potentially noncompliant patients have been eliminated 
at the outset of the trial. Furthermore, the 10% prevalence rate of “advanced” 
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hypertension is calculated as if all patients developed diastolic readings 90-1 14 
at once at the beginning of treatment. 
TABLE 1 illustrates the very real need to improve the prediction of future 
hypertension. Even though borderline hypertension is the strongest known 
predictor of hypertension, it cannot be used as the sole criterion for patient 
selection for treatment. One hundred patients with borderline hypertension 
would have to receive medication for 5 years in order to show benefit at best 
in four and at worst in one subject. This obviously is not a practical proposi- 
tion. Tools for better prediction of future hypertension need to be developed. 
A second illustration will be presented following a discussion of the current 
status of knowlege about predictors of hypertension. 
PREDICTION OF FUTURE HYPERTENSION 
Basically there are two methods to search for prospective patients with 
hypertension, ( 1) provocative tests and (2) descriptive characteristics. 
Provocative Tests 
Many provocative tests are based on the assumption that an exaggerated 
pressor response, if elicited, is representative of a trend toward future hyper- 
tension. The basic assumption that repeated pressor episodes lead to hyper- 
tension has never been properly tested. In  fact, animal experimentation with 
removing arterial baroreceptors in dogs shows that numerous pressor episodes 
do not lead to established hypertension.’J Repeated pressor episodes from 
mental stress in squirrel monkeys,15 from hypothalamic stimulation of rats,ls 
and from “social” stress in mice l7 are said to cause “established” hyperten- 
sion. However, severity of “established” hypertension under these experi- 
mental conditions does not resemble true human established hypertension. A 
malignant hypertension by means of repeated pressor episodes has yet to be 
created. 
Cold Pressor Tesf 
Hines originally proposed that hyperresponsiveness to cold may be a 
useful tool for predicting future hypertension.’* He viewed “labile” hyper- 
tension as a strong precursor of hypertension and found cold pressor hyper- 
responsiveness to be typical for labile hypertension. These expectations have 
not been confirmed in subsequent studies. Hyperresponsiveness to cold is not a 
characteristic trait in borderline hypertension.l8, *O In the normotensive range 
there is no correlation between baseline blood pressure and the cold pressor 
test.21. 22 Finally, the cold pressor test has been evaluated in a prospective study 
and failed to predict future hypertension.22 
Response to Exercise 
C. B. Thomas originally proposed that blood pressure response to exercise 
may be exaggerated in subjects who are prone to later hypertensi~n.~~ How- 
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ever, to our knowledge, in later studies from her laboratory the predictive 
value of exercise responses has not been evaluated. Newer studies with intra- 
arterial blood pressure measurement failed to confirm an excessive blood pres- 
sure response in young subjects with borderline hype r t en~ ion .~~-~’  
Tilt 
It has been shown that tilting causes hypertensive responses in a proportion 
The predictive value of this hyper- of patients with mild hypertension.28* 
reactivity has not been investigated. 
Psychological Stress 
Mental arithmetic elicits a higher pressor response in patients with border- 
line hypertension. This higher response is coupled with more catecholamine 
excretion than in normal Although it is conceptualized that stress 
may lead to hypertension,31 the predictive value of an excessive blood pressure 
response to mental stress has not been established. 
Descriptive Characteristics 
Numerous descriptive variables have been cross-sectionally associated with 
hypertension. One phenomenon may be associated to another as a cause or 
consequence, or in a parallel (related or unrelated) fashion. It therefore can- 
not be expected that all cross-sectional correlates of hypertension will predict 
the devolopment of future hypertension, but some of them may have such a 
predictive potential. Only a few descriptive characteristics have been actually 
investigated for their potential and strength as prospective predictors of the 
development of hypertension. 
Blood Pressure Levels 
It would be beyond the scope of this paper to review the substantial evidence 
that initial blood pressure levels are the strongest single known predictor of 
future hypertension. Longitudinal following of cohorts of individuals shows 
that those who were normotensive, but whose blood pressure was in the upper 
range, exhibited a steeper blood pressure increase with age.’, 32 Analyzed in 
terms of development of “hypertension,” the results are identical; in groups 
whose initial blood pressure was in the upper quintile, there will be more 
individuals with hypertensive blood pressure levels with passage of time.g* 33 
The strength of the blood pressure as predictor by far exceeds the power 
of all other factors that are known to predict future hyperten~ion.~’ Stamler 
et al.34 have shown that the several factors considered in their analyses (age, 
relative weight, heart rate, plasma glucose, serum cholesterol, serum uric acid, 
and cigarettes) are not strongly correlated with followup blood pressure when 
baseline blood pressures and the remaining factors are partialled out. Similar 
results obtain in multiple logistic analyses wherein baseline blood pressures 
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are the only consistent (across cutoff points for elevated followup blood 
pressure) predictors of elevated blood pressure. 
Heart Rate 
Increased heart rate is associated with mild and borderline hypertension.ll 
It is now also clear that elevated heart rate is an independent predictor of future 
hypertension.'@ 33-36 The predictive power, however, appears to be weak.34 
Overweight 
Overweight is associated with mild and borderline hypertension. Relative 
weight is a predictor of future hypertension but, similarly to the heart rate, the 
predictive power is not ~ t r o n g . ~ ~  34 
Family History 
Family history of hypertension is significantly more frequent in patients 
with borderline hypertensi~n.~~ Later hypertension appears to occur more 
frequently in persons with positive family history.37 We could not assess the 
relative predictive strength of these parameters. 
Psychological Factors 
Some distinctive behavioral and personality patterns appear to be associated 
with borderline hyperten~ion.~8-40 The hope that these factors may predict 
future hypertension has not ;materialized. 
Race 
One can construe from the results of the National Health Survey 1960-62 41 
that marginal blood pressure elevation in a black person carries a higher risk 
for future hypertension than in whites. Thus in the overall population aged 
18-79 the prevalence of borderline hypertension in whites and blacks (both 
sexes) is very similar, but definite hypertension is found twice as frequently 
in blacks as in whites. Assuming that in the majority of cases hypertension 
evolves through a phase of borderline blood pressure elevation, it is reasonable 
to postulate that a black person with borderline hypertension has double the 
chance of later developing established hypertension. 
Prediction Based on Multiple Factors 
Until now predictive variables have been considered one at a time. It is 
possible that simultaneous use of a number of variables may be more predictive 
than each variable separately. This proposition has been extensively evaluated 
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in an important recent paper describing the experience of four Chicago epi- 
demiologic Using the multiple logistic function (including variables: 
baseline blood pressures, age, heart rate, serum cholesterol, one-hour plasma 
glucose, relative weight, and hematocrit) to discern that quintile of the popula- 
tion with highest risk of developing hypertension within 5 years, Stamler et ~ 1 . 3 4  
found at most 55% of all expected hypertensives will be in that quintile. Fur- 
ther,-assuming that 10% of the total population from which this quintile has 
been culled will become hypertensive in 5 years, then approximately 27.5% of 
this quintile would become hypertensive. (Fifty-five percent of 10% is 5.5%. 
This 5.5% is to be found in the highest quintile of the population. Thus 27.5% 
[=5.5% X 51 of this quintile must be hypertensive, to represent 5.5% of the 
total population.) 
Prevalence of Hypertension 
in the Highest Risk Quintile 
I 
Distribution 90% 10% (National Health 
Survey) 
Untreated 
Morbidity 55 % 80% (VA Studies) 
Treatment 
Efficacy 67 % 90% (VA Studies) 
Percent of Total 
Population Saved 9.2% 
11.2% 
FIGURE 1. Projection of treatment efficacy using multifactorial hypertension risk 
screening (treat all subjects in the upper quintile of risk). 
We now assess the hypothetical efficacy of antihypertensive treatment in 
this quintile with highest predicted risk, using these results based on Stamler 
et a/.  and those of the Veterans Administration studies.I2- The VA results 
indicate that 55% of those with diastolic blood pressure 90-115 will have a 
morbid event in 5 years, while about 80% of those with diastolic blood pressure 
above 115 would have such an event in 5 years. It is estimated that 90% of 
all hypertensives have diastolic blood pressure 90-115 and 10% are above 
115.” The VA results indicate that treatment can save about 67% of those 
with diastolic 90-115 and 90% of those with diastolic 115+ from a morbid 
event. 
Using calculations similar to those illustrated in TABLE 1 (see FIGURE l ) ,  
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about 11.2% of this highest risk quintile would be saved from a morbid event 
due to hypertension in 5 years (9.2% of those with diastolic blood pressure 
90-115 and 2.0% of those with diastolic blood pressure above 115). 
Therefore, even using the most optimistic figures available, only about 
11.2% of the group predicted to be at highest risk of hypertension would be 
saved from a morbid event. The conclusion is that populations which will con- 
tain the vast majority of future hypertensives must be ascertained with greater 
certitude than presently predictable, if widescale antihypertensive therapy is to 
have appreciable efficacy in large populations. 
PATHOPHYSIOLOGY OF BORDERLINE HYPERTENSION 
As arterial hypertension develops, many secondary cardiovascular changes 
occur. Restructuring of resistance altered cardiac per f~rmance ,~~ 
and resetting of arterial baroreceptors45 are some of the examples. Conse- 
quently, many investigators have focused on “prehypertension” in the hope of 
finding a model of very mild hypertension free of secondary pressure-related 
changes. The limitations of this approach are obvious from the previous sec- 
tions. Marginal blood pressure elevation is the strongest predictor of future 
hypertension, but the incidence of future hypertension is low. Consequently it 
is not known which observations in borderline hypertension are pertinent and 
which are not related to the later development of hypertension. The problem 
becomes particularly clear when one considers the wide range of abnormalities 
observed in borderline hypertension, shown in TABLE 2. Two points emerge 
from TABLE 2: (1 ) Borderline hypertension is not just a “little blood pressure 
elevation”; a number of physiologic aberrations are observed. Many of these 
abnormalities were found in patients who had a history of occasional blood 
pressure elevation, but during the laboratory testing were normotensive. Behind 
the facade of borderline hypertension, unrelated to the blood pressure elevation, 
a complex of physiologic abnormalities can be detected. (2) From a physiolo- 
gist’s viewpoint, borderline hypertension is not a homogeneous disease. Some 
of the abnormalities are polar (high and low stroke volume, high and low 
plasma renin activity), some are present only in a minority of patients (elevated 
cardiac output, redistribution of the blood in the capacity space, decreased 
plasma volume) whereas those present in all patients (abnormal peripheral 
resistance) may be coupled with the presence or absence of other abnormalities. 
The complexity of changes in borderline hypertension militates against the 
simplified statistical view of hypertension as the upper end of the normal blood 
pressure distribution. Failure to demonstrate two separate peaks of blood pres- 
sure distribution does not preclude the possibility that the development of blood 
pressure in various individuals occurred through different mechanisms. The 
variety of findings in borderline hypertension offers the exciting possibility that 
occurrence of hypertension may be favored or delayed by some of these abnor- 
malities, and that some other observations may be entirely unrelated to the 
development of later hypertension. Only epidemiologic studies can provide the 
answer. 
Clustering of some of the pathophysiologic abnormalities into certain pat- 
terns provides further support for the assumption that borderline hypertension 
is not a homogeneous condition and groups with such patterns may have differ- 
ent natural histories. Description of patterns very much depends on the investi- 
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gator’s interest. For example, the level of plasma volume may be chosen as the 
primary descriptor and other correlates could then be analyzed. In the labora- 
tory in Ann Arbor, the role of the autonomic nervous system is under special 
scrutiny. Our research findings are presented only as an illustration of patho- 
physiologic patterns that could conceivably be used to determine future research 
strategies. 
TABLE 2
PHYSIOLOGIC ABNORMALITIES IN BORDERLINE HYPERTENSION * 
1. Biochemical indices of sympathetic activity elevated 
2. Cardiac index elevated 
3. Tachycardia ’’ 




inappropriately adjusted to flow ’’ 
5 .  Peripheral resistance abnormal 
6. Peripheral to central distribution of the blood in the 
capacitance vessels ’* 
7. Plasma volume decreased 
8. Plasma renin activity abnormal 
high ‘’ 
low 54 
9. Vascular reactivity-increased 
10. Increased blood pressure responsiveness 
to tilt iB 
to mental stress Jo 
of the heart 
of renin release ’’ 
1 1. Increased beta-adrenergic responsiveness 
12. Abnormal forearm blood flow response to sodium loading 68 
* Typical references for various observations are given; detailed reference can be 
found in a recent review.” 
“Neurogenic” Borderline Hypertension 
In these patients the cardiac output is elevated through a combination of a 
faster heart rate and a larger stroke This elevation is neurogenic; 
after cardiac autonomic blockade with propranolol and atropine, the stroke 
volume and heart rate return into the normal range.s0 Peripheral resistance in 
these cases is elevated through an increased alpha-adrenergic tone.5* After 
alpha-adrenergic blockade with phentolamine, the vascular resistance normalizes. 
In this “neurogenic” borderline hypertension the cardiac sympathetic drive 
is increased, whereas the vagal inhibition of the heart is decreased.so Such a 
reciprocal relationship of the sympathetic and parasympathetic efferent tone is 
typical for the functional organization of the integrative areas in the medulla 
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oblongata. Thus the abnormality is not likely to reside in the peripheral neurons; 
an abnormal but integrated pattern of changes is 
It is now becoming evident that elevations of the plasma renin activity in 
borderline hypertension is also a part of the “neurogenic” pattern. Bimodal 
elevation of plasma renin activity described by Frohlich et aL4’ was an early 
indication that high plasma renin in mild and severe hypertension may have 
different pathophysiologic significance. Esler et d.”* have shown that patients 
with high-renin borderline hypertension exhibit an increased alpha-adrenergic 
tone, and that the renin elevation per se is not responsible for the blood pressure 
elevation in such patients. 
In this light, our recent study in patients with mild established hypertension 
who had a high plasma renin is of particular interest.s1 In the absence of longi- 
tudinal studies, assumptions can be made from cross-sectional studies of various 
degrees of severity of hypertension. It is reasonable to assume that mild estab- 
lished hypertension (systolic always 150-160, diastolic 95-1 05) evolves from 
previous borderline hypertension (blood pressure above and below 140/90). 
Pathophysiologic similarities, if found in both “stages,” may delineate those 
abnormalities in borderline hypertension that are likely related to the develop- 
ment of hypertension. Patients with high-renin established hypertension show 
essentially the same changes as the “neurogenic” subset of borderline hyper- 
tension. The cardiac output tends to be elevated and there is evidence of in- 
creased beta- and alpha-adrenergic drive. Furthermore, plasma catecholamine 
levels in such patients are elevated. 
Further support for the possible pathogenic significance of the “neurogenic” 
borderline hypertension comes from epidemiologic studies. Tachycardia, which 
is the most consistent feature of the “neurogenic” borderline hypertension, has 
been shown in a number of studies to be an independent predictor of future 
hypertensi~n.~. 33-a5 
“Non-neurogenic” Borderline Hypertension 
The opposite end of the spectrum, the “non-neurogenic” borderline hyper- 
tension, also may have an elevated cardiac output. However, in these patients 
there is an isolated elevation of the stroke volume, whereas the heart rate is 
normal.s2 Such patients have a redistribution of the blood in the capacity space; 
total blood volume is normal, but a larger proportion is maintained in the 
cardiopulmonary space.Sz The elevated stroke volume appears to reflect effects 
of this volume distribution on cardiac performance. Cardiac output in these 
patients does not return to normal after cardiac autonomic blockade, and their 
peripheral resistance remains elevated after additional alpha-adrenergic blockade 
with phentolamine. Plasma renin activity in such patients is decreased. 
Similarly, as in high-renin borderline hypertension, this pattern shows some 
pathogenic similarity with low-renin established hype r t ens i~n .~~  Catecholamine 
levels, response to tyramine, response to autonomic blockade in patients with 
low-renin established hypertension are indicative of a low sympathetic tone. 
However, established low-renin hypertension does not show such a homogeniety 
of hemodynamic patterns as high-renin established hypertension. Only a sub- 
group of low-renin established hypertension has similar hemodynamic features 
as low-renin borderline hypertension. 
Julius & Schork: Predictors of Hypertension 47 
OPPORTUNITIES FOR FUTURE RESEARCH 
The pathophysiology of precursors of hypertension has already been investi- 
gated in selected population studies by E i ~ h , ~ ~  Lund-Johan~en,~~ Finkielman 
et al.,BZ Bello et al.,66 and Julius and Conway 25 who included only male subjects. 
Sannerstedt,z6 Frohlich et al.,” and Widimsky et dB7 included a small propor- 
tion of females in their studies. Populations in these studies were largely de- 
termined by local referral and hospitalization patterns. Lund-Johansen’s study 24 
was drawn from a large population, but the selection for laboratory studies was 
not random. Only one study 68 analyzed hemodynamic patterns in a longitudinal 
fashion, but the population was too small to provide meaningful conclusions. 
Descriptive epidemiologic studies of precursors of hypertension are charac- 
terized by an ever improving design and a higher level of sophistication of data 
analysis. Nevertheless it remains a fact that in the last two decades they have 
dealt with essentially the same variables. Whereas twin and family studies may 
improve our knowledge in the future, it is evident that hypertension is not a 
single entity and certainly not a single-gene disease. In whom, why and how 
does the tendency to hypertension express itself will still remain an open 
question. 
Real progress can only be made if the expertise in both fields is combined. 
There should be a move from descriptive epidemiology and laboratory studies 
on selected populations, to investigations of pathophysiology in an epidemiologic 
setting. 
A number of non-invasive tests of hemodynamics are now available. Cardiac 
output can be estimated by echocardiography and by the carbon dioxide re- 
breathing method. Systolic time intervals provide a new dimension in assessing 
myocardial contractility. Measurement of plasma volume by Evans blue remains 
a safe and simple procedure. Responsiveness to pharmacologic blockade can 
be used to assess the neurogenic drive. Measurements of plasma catecholamines 
are now sensitive and precise. Plasma renin activity can be measured, but in 
the future we may rely also on blood pressure responses to angiotensin antago- 
nists. Determination of circulating angiotensin I1 levels may soon become 
dependable. Better assays of prostaglandins will be available. Urinary kallikrein 
has already been measured in an epidemiologic 
A number of these and other methods can be used in prospective studies to 
enhance the understanding of hypertension. In cross-sectional investigation, 
analysis of family sets and twin studies of various physiologic variables are 
particularly promising approaches. 
Although many more examples can be found, we will illustrate four major 
categories where combining the epidemiologic and pathophysiologic approaches 
may yield important results. No attempt is made to define “epidemiologic.” 
Obviously in some studies noninvasive methods may be applied in large popula- 
tions whereas in other instances precise physiologic measurements in representa- 
tive samples of populations chosen for various levels of risk may be indicated. 
Evaluation of Pathophysiologic Concepts 
The hyperkinetic state offers a good illustration.60 It has been postulated 
that hypertension is initiated by a primary increase of the cardiac output which 
triggers a later “autoregulatory” increase of the peripheral re~istance.’~ The 
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following questions should be asked: Is there evidence of a high cardiac output 
state in offspring of hypertensive parents before they exhibit hypertension? In 
prospective studies, do subjects with the hyperkinetic state tend to develop more 
hypertension than control subjects? For the same levels of marginal blood 
pressure elevation, does the hypertension develop more frequently and/or over 
a shorter period of time in the “hyperkinetic” or “high resistance” type of 
borderline hypertension? Are all hyperkinetic states the same, or does there 
exist a “neurogenic” and “volume” subset of subjects with elevated cardiac 
output-what is their prognosis? 
Other pathophysiologic concepts also deserve attention. Is there good evi- 
dence for vascular hyperreactivity in precursors of hypertension? Can the 
precursors of hypertension be differentiated into “volume” and “vasoconstrictor” 
states and which one predicts more future hypertension? What is the role of 
the autonomic nervous system in the development of essential hypertension? 
Mechanisms of Risk Factors for Hypertension 
Overweight and hypertension lend themselves as ideal examples. The asso- 
ciation between overweight and hypertension is well-documented.s. 31 What is 
its mechanism? Does increase of weight lead to blood pressure increases in 
everybody or only in selected cases? We suspect the latter to be the case. If so, 
what are the characteristics of such subjects? Do they show excessive plasma 
volume expansion for a given increase of weight; do their cardiac outputs and 
stroke volumes reflect volume effects on cardiac performance? Or, is increased 
appetite-weight gain an expression of increased “nervousness”; what are the 
catecholamine levels, psychometric characteristics, and indices of cardiac sym- 
pathetic activity in such subjects? 
Evaluation of Physiologic Variables as Possible Precursors of Hypertension 
A number of known correlates of borderline hypertension have not been 
investigated as prospective predictors of hypertension. Of specific interest here 
is the plasma volume, levels of catecholamines, renin levels and renin de- 
pendency of the blood pressure, differentiation between vagal and sympathetic 
tachycardia, state of peripheral vascular resistance, alpha-adrenergic dependency 
of the blood pressure and volume distribution in the capacity space. 
Possible New Provocative Tests 
A recent article by Mark and associates 6 8  suggests to us that sodium loading 
may be a useful tool in evaluation of future hypertension. In short, they found 
that normotensive subjects on sodium loading decrease the forearm vascular 
resistance, whereas in patients with borderline hypertension on sodium load the 
forearm resistance increased. This opens a number of important and interesting 
possibilities. Can prediction of hypertension be improved by observing blood 
pressure, plasma volume, forearm flow, cardiac output, renin, and kallikrein 
responses to sodium loading? 
It has already been pointed out earlier that blood pressure responses to 
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tilting and mental stress deserve scrutiny as possible predictors of hypertension. 
The specific examples in four categories are given only as an illustration of 
a variety of projects which could spring from cooperation between investigators 
with different backgrounds. Interaction between those familiar with mechanisms 
and those interested in epidemiology of hypertension could not fail to open 
new avenues in the search for precursors of hypertension. 
Summary 
The main justification of a search for predictors of future hypertension is 
in the hope of identifying a population in which it would be reasonable to 
initiate preventive antihypertensive treatment. We examined all the known risk 
factors for hypertension and found that, based on the present evidence in the 
literature, such a group cannot be selected. 
A large body of information exists in the area of pathophysiology of "pre- 
hypertension," but this has never been used in an epidemiologic context. It is 
hoped that incorporation of new measurements testing various pathophysiologic 
alterations in future epidemiologic studies may improve prediction and provide 
insight into mechanisms of hypertension. 
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